Pirolazamide
Pirolazamide
 |
| Systematic (IUPAC) name |
|---|
|
4-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-2,2-diphenylbutanamide |
| Clinical data |
|---|
| Identifiers |
|---|
|
39186-49-7  N |
|---|
|
None |
|---|
| PubChem |
CID 71442 |
|---|
| ChemSpider |
64526  Y |
|---|
| UNII |
GQN5BVM24W Y |
|---|
| KEGG |
D05509 Y |
|---|
| Chemical data |
|---|
| Formula |
C23H29N3O |
|---|
|
363.502 g/mol |
|---|
SMILES
- O=C(N)C(c1ccccc1)(c2ccccc2)CCN4CC3N(CCC3)CC4
|
InChI=1S/C23H29N3O/c24-22(27)23(19-8-3-1-4-9-19,20-10-5-2-6-11-20)13-15-25-16-17-26-14-7-12-21(26)18-25/h1-6,8-11,21H,7,12-18H2,(H2,24,27)
Y
Key:SEINJQWGYXAADT-UHFFFAOYSA-N
Y
|
| N (what is this?) (verify) |
|---|
Pirolazamide (SC-26,438) is an antiarrhythmic agent that was never marked.[1]
References